Dietary Fat, Fiber, and Carbohydrate Intake and Endogenous Hormone Levels in Premenopausal Women

Hormones and Cancer

Volumn 1, Issue 5, 2010, Pages 265-276

  Cui, Xiaohui ^a   Rosner, Bernard ^a,b   Willett, Walter C ^a,b   Hankinson, Susan E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Dietary carbohydrates; Dietary fats; Dietary fiber; Gonadal steroid hormones; Insulin like growth factor binding protein 3; Insulin like growth factor I

Indexed keywords

ANDROGEN; CONNECTIVE TISSUE GROWTH FACTOR; ESTROGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD SAMPLING; CARBOHYDRATE INTAKE; DIETARY FIBER; FAT INTAKE; FEMALE; HORMONE DETERMINATION; HUMAN; MENOPAUSE; PRIORITY JOURNAL;

ADULT; ANDROGENS; CARBOHYDRATES; CROSS-SECTIONAL STUDIES; DIET; DIETARY FATS; DIETARY FIBER; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; PREMENOPAUSE;

EID: 78650223818     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-010-0050-6     Document Type: Article

References (80)

1. Potischman NR, Hoover N, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML et al (1996) Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 88(16): 1127-1135.
2. Austin H, Austin JM Jr, Partridge EE, Hatch KD, Shingleton HM (1991) Endometrial cancer, obesity, and body fat distribution. Cancer Res 51(2): 568-572.
3. Mollerstrom G, Carlstrom K, Lagrelius A, Einhorn N (1993) Is there an altered steroid profile in patients with endometrial carcinoma? Cancer 72(1): 173-181.
4. Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomark Prev 11(12): 1531-1543.
5. Zeleniuch-Jacquotte A, Shore RE, Koenig KL, Akhmedkhanov A, Afanasyeva Y, Kato I, Kim MY, Rinaldi S, Kaaks R, Toniolo P (2004) Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 90(1): 153-159.
6. ESHRE Capri Workshop Group (2004) Hormones and breast cancer. Hum Reprod Update 10(4): 281-293.
7. Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7(1): 3-15.
8. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8): 606-616.
9. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96(24): 1856-1865.
10. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L et al (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12(4): 1071-1082.
11. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE (2006) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98(19): 1406-1415.
12. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97(10): 755-765. doi: 97/10/755[pii]10. 1093/jnci/dji132.
13. Riman T, Nilsson S, Persson IR (2004) Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83(9): 783-795.
14. Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90(23): 1774-1786.
15. Tentori L, Graziani G (2007) Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk? Pharmacol Res 55(5): 359-369.
16. Jenkins PJ, Mukherjee A, Shalet SM (2006) Does growth hormone cause cancer? Clin Endocrinol (Oxf) 64(2): 115-121.
17. Moschos SJ, Mantzoros CS (2002) The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63(4): 317-332.
18. Furstenberger G, Senn HJ (2002) Insulin-like growth factors and cancer. Lancet Oncol 3(5): 298-302.
19. Kaaks R (2004) Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 262: 247-260, discussion 260-268.
20. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279(5350): 563-566.
21. Monti S, Proietti-Pannunzi L, Sciarra A, Lolli F, Falasca P, Poggi M, Celi FS, Toscano V (2007) The IGF axis in prostate cancer. Curr Pharm Des 13(7): 719-727.
22. Giovannucci E (1999) Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res 51(Suppl 3): 34-41.
23. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ et al (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149(7): 461-471, W483-468.
24. Shi R, Yu H, McLarty J, Glass J (2004) IGF-I and breast cancer: a meta-analysis. Int J Cancer 111(3): 418-423.
25. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351(9113): 1393-1396.
26. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363(9418): 1346-1353.
27. Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, Ashworth A, Peto J, Silva Idos S (2005) Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomark Prev 14(1): 2-19.
28. Lann D, LeRoith D (2008) The role of endocrine insulin-like growth factor-I and insulin in breast cancer. J Mammary Gland Biol Neoplasia 13(4): 371-379.
29. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91(7): 620-625.
30. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE (2000) A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomark Prev 9(4): 345-349.
31. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J et al (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101(1): 48-60.
32. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X (1999) Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91(2): 151-156.
33. Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS (1998) Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9(5): 570-573.
34. Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V et al (2004) Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108(3): 425-432.
35. Bandera EV, Kushi LH, Moore DF, Gifkins DM, McCullough ML (2007) Association between dietary fiber and endometrial cancer: a dose-response meta-analysis. Am J Clin Nutr 86(6): 1730-1737.
36. Xu WH, Dai Q, Xiang YB, Zhao GM, Ruan ZX, Cheng JR, Zheng W, Shu XO (2007) Nutritional factors in relation to endometrial cancer: a report from a population-based case-control study in Shanghai, China. Int J Cancer 120(8): 1776-1781.
37. Littman AJ, Beresford SA, White E (2001) The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control 12(8): 691-702.
38. Zhang M, Lee AH, Binns CW (2004) Reproductive and dietary risk factors for epithelial ovarian cancer in China. Gynecol Oncol 92(1): 320-326.
39. La Vecchia C (2001) Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 10(2): 125-129.
40. Edefonti V, Decarli A, La Vecchia C, Bosetti C, Randi G, Franceschi S, Dal Maso L, Ferraroni M (2008) Nutrient dietary patterns and the risk of breast and ovarian cancers. Int J Cancer 122(3): 609-613.
41. Pelucchi C, La Vecchia C, Chatenoud L, Negri E, Conti E, Montella M, Calza S, Dal Maso L, Franceschi S (2001) Dietary fibres and ovarian cancer risk. Eur J Cancer 37(17): 2235-2239.
42. Trock B, Lanza E, Greenwald P (1990) Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 82(8): 650-661.
43. Prentice RL, Sheppard L (1990) Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1(1): 81-97, discussion 99-109.
44. Slattery ML, Benson J, Berry TD, Duncan D, Edwards SL, Caan BJ, Potter JD (1997) Dietary sugar and colon cancer. Cancer Epidemiol Biomark Prev 6(9): 677-685.
45. Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, Woods MN (1982) Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med 307(25): 1542-1547.
46. Goldin BR, Adlercreutz H, Gorbach SL, Woods MN, Dwyer JT, Conlon T, Bohn E, Gershoff SN (1986) The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 44(6): 945-953.
47. Thissen JP, Ketelslegers JM, Underwood LE (1994) Nutritional regulation of the insulin-like growth factors. Endocr Rev 15(1): 80-101.
48. Holmes MD, Pollak MN, Willett WC, Hankinson SE (2002) Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomark Prev 11(9): 852-861.
49. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS (1999) Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. J Clin Oncol 17(10): 3291-3298.
50. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K (2003) Dietary soy and fats in relation to serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 levels in premenopausal Japanese women. Nutr Cancer 45(2): 185-189.
51. Norat T, Dossus L, Rinaldi S, Overvad K, Gronbaek H, Tjonneland A, Olsen A et al (2007) Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 61(1): 91-98.
52. Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, Sacks FM, Stampfer MJ (1989) Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 35(12): 2313-2316.
53. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE (2006) Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in the nurses health study II. Endocr Relat Cancer 13(2): 583-592.
54. Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66(4): 2476-2482.
55. Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE (2006) Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J Clin Oncol 24(12): 1823-1830.
56. Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE (2006) The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomark Prev 15(5): 967-971.
57. Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE (2006) Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomark Prev 15(5): 972-978.
58. Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC (1989) Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 18(4): 858-867.
59. Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New York.
60. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC (1992) Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135(10): 1114-1126, discussion 1127-1136.
61. Holmes MD, Spiegelman D, Willett WC, Manson JE, Hunter DJ, Barbieri RL, Colditz GA, Hankinson SE (2000) Dietary fat intake and endogenous sex steroid hormone levels in postmenopausal women. J Clin Oncol 18(21): 3668-3676.
62. Haytowitz DB (1995) Information from USDA's nutrient data bank. J Nutr 125(7): 1952-1955.
63. Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25: 165-172.
64. Wu AH, Pike MC, Stram DO (1999) Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91(6): 529-534.
65. Holmes MD, Schisterman EF, Spiegelman D, Hunter DJ, Willett WC (1999) Re: meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91(17): 1511-1512.
66. Rose DP, Goldman M, Connolly JM, Strong LE (1991) High-fiber diet reduces serum estrogen concentrations in premenopausal women. Am J Clin Nutr 54(3): 520-525.
67. Gann PH, Chatterton RT, Gapstur SM, Liu K, Garside D, Giovanazzi S, Thedford K, van Horn L (2003) The effects of a low-fat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the diet and hormone study). Cancer 98(9): 1870-1879.
68. Brown BD, Thomas W, Hutchins A, Martini MC, Slavin JL (2002) Types of dietary fat and soy minimally affect hormones and biomarkers associated with breast cancer risk in premenopausal women. Nutr Cancer 43(1): 22-30.
69. Nagata C, Takatsuka N, Kawakami N, Shimizu H (2000) Total and monounsaturated fat intake and serum estrogen concentrations in premenopausal Japanese women. Nutr Cancer 38(1): 37-39.
70. Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C, Schatzkin A, Forman M et al (1996) Relation of energy, fat, and fiber intakes to plasma concentrations of estrogens and androgens in premenopausal women. Am J Clin Nutr 64(1): 25-31.
71. Aubertin-Leheudre M, Gorbach S, Woods M, Dwyer JT, Goldin B, Adlercreutz H (2008) Fat/fiber intakes and sex hormones in healthy premenopausal women in USA. J Steroid Biochem Mol Biol 112(1-3): 32-39.
72. Schaefer EJ, Lamon-Fava S, Spiegelman D, Dwyer JT, Lichtenstein AH, McNamara JR, Goldin BR et al (1995) Changes in plasma lipoprotein concentrations and composition in response to a low-fat, high-fiber diet are associated with changes in serum estrogen concentrations in premenopausal women. Metabolism 44(6): 749-756.
73. Maskarinec G, Morimoto Y, Takata Y, Murphy SP, Stanczyk FZ (2006) Alcohol and dietary fibre intakes affect circulating sex hormones among premenopausal women. Public Health Nutr 9(7): 875-881.
74. Heald AH, Golding C, Sharma R, Siddals K, Kirk S, Lawton C, Anderson S, Martin Gibson J, Cade JE (2004) A substitution model of dietary manipulation is an effective means of optimising lipid profile, reducing C-reactive protein and increasing insulin-like growth factor-1. Br J Nutr 92(5): 809-818.
75. Al-Delaimy WK, Natarajan L, Rock CL, Sun S, Flatt SW, Pierce JP (2006) Insulin-like growth factor I, insulin-like growth factor I binding protein 1, insulin, glucose, and leptin serum levels are not influenced by a reduced-fat, high-fiber diet intervention. Cancer Epidemiol Biomark Prev 15(6): 1238-1239.
76. Gann PH, Kazer R, Chatterton R, Gapstur S, Thedford K, Helenowski I, Giovanazzi S, van Horn L (2005) Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women. Int J Cancer 116(2): 297-303.
77. Kaaks R, Bellati C, Venturelli E, Rinaldi S, Secreto G, Biessy C, Pala V, Sieri S, Berrino F (2003) Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the diet and androgens (DIANA) randomised trial. Eur J Clin Nutr 57(9): 1079-1088.
78. Maskarinec G, Takata Y, Kaaks R (2005) The relation between nutritional factors and insulin-like growth factor-I in premenopausal women of different ethnicity. Eur J Nutr 44(2): 105-113.
79. Hu FB, Stampfer MJ, Manson JE et al (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337(21): 1491-1499.
80. Wolk A, Manson JE, Stampfer MJ, Colditz GA, Hu FB, Speizer FE, Hennekens CH, Willett WC (1999) Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 281(21): 1998-2004.